Hyosung Chemical to Invest $34.5M in Private Equity Fund — 7.9% of Equity Capital

Hyosung Chemical (298000) disclosed on May 6, 2026 via DART that it has resolved to invest $34.5M as a limited partner in Aurora Growth Partnership Fund III, operated by Aurora Partners. This represents 7.9% of the company's consolidated equity capital of $4.37B as of end-2025.

Why Hyosung Chemical — Diversifying Investment Returns Amid Persistent Losses

The Aurora Growth Partnership Fund III is a newly established private collective investment vehicle established on March 12, 2026 with capital of $34.5M. Aurora Partners, as operator and representative, manages the fund. Since participation occurs through the LP (limited partner) structure without new share issuance, neither the number of shares nor equity stake acquired by Hyosung Chemical is disclosed.

Hyosung Chemical stated the investment purpose as 'expected future investment returns.' The acquisition method is cash, and the scheduled investment date is June 8, 2026. However, the date may change according to the Fair Trade Commission's merger review approval schedule. The $34.5M investment represents 1.93% of the company's consolidated total assets of $17.89B as of end-2025. The company also disclosed that no reverse listing applies, no put option agreements exist, and FTC reporting requirements do not apply.

Hyosung Chemical Status — Q1 Net Loss of $120.8M; Delisting Review Underway

The investment decision comes as Hyosung Chemical faces mounting financial strain. According to Digital Today reporting, Hyosung Chemical recorded a net loss of $120.8M in Q1 2026, marking a swing to losses versus the prior year. Forth Journal reported that Hyosung Chemical is entering the final phase of its remediation period, with a delisting decision expected in May 2026. Smart Today noted that despite weak performance by major competitors like LG Chemical and Lotte Chemical, Hyosung Chemical is showing signs of loss recovery focused on high-margin products.

Chemicals Sector Trends — Shift Toward High-Margin Products

• Hyosung Chemical (298000): Restructuring toward specialty gases and polypropylene; delisting review ongoing.
• Hyosung (004800): Operating performance improving on strong subsidiary power equipment and data center demand (Forth Journal).
• Kumho Petrochem: Loss recovery underway with focus on high-margin product portfolio (Smart Today).
• LG Chemical: Continued weakness in chemicals division in Q1 (Smart Today).
• Lotte Chemical: Structural reorganization underway amid sluggish commodity petrochemicals (Smart Today).

Hyosung Chemical's private fund investment appears to reflect an attempt to diversify revenue streams as profitability recovery in its core petrochemicals business remains delayed. While the $34.5M represents only 1.93% of total assets, a company posting net losses exceeding $120.8M in Q1 deploying $34.5M cash into an external fund warrants liquidity management scrutiny. With delisting review proceedings ongoing, investors should cross-reference the original disclosure with Korea Exchange review outcomes. Highly uncertain securities can exhibit significant volatility, and risk assessment is essential before trading.

This article was auto-generated from DART disclosure and external reporting with the objective of rapid core data dissemination following announcement. Confirmation of official company disclosures is recommended before trading decisions. Disclosure link: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260506800922